3-iodobenzylguanidine has been researched along with atrial natriuretic factor in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 8 (72.73) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, H; Ashihara, T; Egashira, S; Fukuyama, T; Imamura, Y; Masaki, H; Mitsuoka, W | 1 |
| Ando, H; Ashihara, T; Fukuyama, T; Imamura, Y | 1 |
| Fujimura, M; Ishida, Y; Komamura, K; Miyatake, K; Nakatani, S; Yamagishi, M; Yasumura, Y | 1 |
| Aoki, S; Makino, K; Nomura, Y; Okamoto, R; Okamoto, S; Saitou, K; Takeda, K; Yahara, Y | 1 |
| Fukuyama, T; Imamura, Y; Miyagawa, M; Mochizuki, T; Watanabe, K | 1 |
| Fukushima, N; Horiguchi, K; Matsuda, H; Matsumiya, G; Miyagawa, S; Nishimura, M; Ohtake, S; Sawa, Y; Taketani, S | 1 |
| Hanatani, A; Hirooka, K; Hori, M; Ishida, Y; Komamura, K; Miyatake, K; Nakatani, S; Yamagishi, M; Yasumura, Y | 1 |
| Ashino, K; Ebina, T; Inoue, T; Ishigami, T; Ishikawa, Y; Kuji, N; Matsubara, S; Minamisawa, K; Mitani, I; Ochiai, H; Oka, T; Sumita, S; Takahashi, N; Umemura, S | 1 |
| Fukuda, N; Onose, Y; Sakabe, K; Shinohara, H; Soeki, T; Tamura, Y | 1 |
| Ichikawa, S; Ishikawa, T; Kasama, S; Kumakura, H; Kurabayashi, M; Suzuki, T; Takayama, Y; Toyama, T | 1 |
| Ichikawa, S; Iwasaki, T; Kasama, S; Kumakura, H; Kurabayashi, M; Matsumoto, N; Minami, K; Nakata, T; Sumino, H; Toyama, T | 1 |
4 trial(s) available for 3-iodobenzylguanidine and atrial natriuretic factor
| Article | Year |
|---|---|
Prognostic value of iodine-123-metaiodobenzylguanidine imaging and cardiac natriuretic peptide levels in patients with left ventricular dysfunction resulting from cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Aged; Atrial Natriuretic Factor; Cardiomyopathies; Death; Disease-Free Survival; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Regression Analysis; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
Comparative left ventricular functional and neurohumoral effects of chronic treatment with carvedilol versus metoprolol in patients with dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adult; Atrial Natriuretic Factor; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Chronic Disease; Female; Hemodynamics; Humans; Male; Metoprolol; Middle Aged; Natriuretic Peptide, Brain; Neurotransmitter Agents; Norepinephrine; Propanolamines; Therapeutic Equivalency; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left | 2001 |
Clinical implications of cardiac (123)I-meta-iodobenzylguanidine scintigraphy and cardiac natriuretic peptides in patients with heart disease.
Topics: 3-Iodobenzylguanidine; Angina Pectoris; Atrial Natriuretic Factor; Cardiomyopathies; Chronic Disease; Female; Follow-Up Studies; Heart Diseases; Heart Valve Diseases; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Natriuretic Peptide, Brain; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2002 |
Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity in patients with decompensated congestive heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Atrial Natriuretic Factor; Cardiotonic Agents; Dopamine; Drug Combinations; Female; Furosemide; Heart; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sympathetic Nervous System; Treatment Outcome; Ventricular Dysfunction, Left | 2004 |
7 other study(ies) available for 3-iodobenzylguanidine and atrial natriuretic factor
| Article | Year |
|---|---|
Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying cause.
Topics: 3-Iodobenzylguanidine; Aged; Atrial Natriuretic Factor; Female; Heart; Heart Failure; Humans; Iodine Radioisotopes; Iodobenzenes; Liver; Male; Mediastinum; Middle Aged; Norepinephrine; Radionuclide Imaging; Sympathetic Nervous System; Ventricular Function, Left | 1995 |
Myocardial adrenergic nervous activity is intensified in patients with heart failure without left ventricular volume or pressure overload.
Topics: 3-Iodobenzylguanidine; Atrial Natriuretic Factor; Cardiac Catheterization; Cardiac Output; Case-Control Studies; Contrast Media; Echocardiography, Doppler; Female; Heart; Heart Failure; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Mitral Valve Stenosis; Norepinephrine; Radionuclide Imaging; Sympathetic Nervous System; Time Factors; Ventricular Function, Left; Ventricular Pressure | 1996 |
Improvement in left ventricular function in response to carvedilol is accompanied by attenuation of neurohumoral activation in patients with dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adult; Aged; Atrial Natriuretic Factor; Biomarkers; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Female; Heart Ventricles; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Propanolamines; Radiopharmaceuticals; Recovery of Function; Retrospective Studies; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Function, Left | 2000 |
[Assessment of most appropriate background subtraction method for quantification of 123I-metaiodobenzylguanidine (MIBG) myocardial uptake by comparing with plasma ANP and BNP].
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Biomarkers; Female; Heart; Heart Failure; Humans; Iodine Radioisotopes; Male; Middle Aged; Natriuretic Peptide, Brain; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index; Stroke Volume; Subtraction Technique | 2000 |
Analysis of sympathetic nerve activity in end-stage cardiomyopathy patients receiving left ventricular support.
Topics: 3-Iodobenzylguanidine; Adult; Atrial Natriuretic Factor; Cardiomyopathies; Echocardiography; Female; Heart Failure; Heart-Assist Devices; Humans; Male; Middle Aged; Myocardium; Natriuretic Peptide, Brain; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System | 2001 |
Effects of angiotensin II receptor antagonists on [(123)I]metaiodobenzylguanidine myocardial imaging findings and neurohumoral factors in chronic heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atrial Natriuretic Factor; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; Creatinine; Echocardiography; Female; Heart; Heart Failure; Humans; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Neurotransmitter Agents; Norepinephrine; Potassium; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Angiotensin; Renin; Severity of Illness Index; Statistics as Topic; Stroke Volume; Tetrazoles; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left | 2002 |
Evaluation of cardiac sympathetic nerve activity and aldosterone suppression in patients with acute decompensated heart failure on treatment containing intravenous atrial natriuretic peptide.
Topics: 3-Iodobenzylguanidine; Administration, Intravenous; Aged; Aldosterone; Atrial Natriuretic Factor; Female; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Organ Size; Radionuclide Imaging; Sympathetic Nervous System | 2014 |